Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus

Journal of Hospital Infection

Volumn 16, Issue 4, 1990, Pages 351-377

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; ALCOHOL; CETRIMIDE; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CHLORINE; CIPROFLOXACIN; CLEARSOL; DETERGENT; DISINFECTANT AGENT; DOMESTOS; FUSIDIC ACID; HEXACHLOROPHENE; HYCOLIN; METICILLIN; NEOMYCIN; PHENOL DERIVATIVE; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TRICLOSAN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTISEPSIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COST; DISINFECTION; EPIDEMIC; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; PATIENT TRANSPORT; SCREENING; STAPHYLOCOCCUS AUREUS;

CROSS INFECTION; DISINFECTION; GREAT BRITAIN; HUMAN; METHICILLIN RESISTANCE; ORGANIZATIONAL POLICY; PATIENT ISOLATION; PERSONNEL, HOSPITAL; SOCIETIES, HOSPITAL; STAPHYLOCOCCAL INFECTIONS;

EID: 0025646349     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/0195-6701(90)90008-C     Document Type: Article

References (65)

1. Dispersal and skin carriage of staphylococci in healthy male and female subjects and patients with skin disease
2. Vancomycin, red neck syndrome and fits
3. Mupirocin-resistant Staphylococcus aureus
4. Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit
5. Shedding of Staph. aureus by human carriers
6. Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus
7. Severe staphylococcal infections treated with vancomycin
8. Pancytopenia associated with vancomycin
9. The effect of mupirocin on the nasal carriage of Staphylococcal aureus
10. In-vitro activity of mupirocin (‘pseudomonic acid’) against Clinical isolates of Staphylococcus aureus
11. Mupirocin—a promising new antimicrobial for topical use
12. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus
13. Methicillin-resistant Staphylococcus aureus bacteraemia in Hong Kong
14. Allergy, red man syndrome, and vancomycin
15. Vancomycin revisited
16. Epidemic methicillin-resistant Staphylococcus aureus
17. Control of epidemic methicillin-resistant Staphylococcus aureus
18. A hospital computer system as a tool for infection control
19. Staff carriage of epidemic methicillin-resistant Staphylococcus aureus
20. The ‘red man's syndrome’ and slow infusion of vancomycin
21. Eradicating staphylococci
22. New method for typing Staphylococcus aureus resistant to methicillin
23. Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital
24. A comparison of the bactericidal activity of various agents against epidemic methicillin-resistant Staphylococcus aureus (EMRSA)
25. Staphylococcus aureus endocarditis: combined therapy with vancomycin and rifampicin
26. In-vitro effects of vancomycin, rifampicin and fusidic acid, alone and in combination against methicillin-resistant Staphylococcus aureus
27. Comparison of in-vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies
28. Evaluation of electrophoretic methods for typing methicillin-resistant Staphylococcus aureus
29. Teicoplanin-resistant coagulase-negative staphylococcus
30. Failure to prevent emergence of bacterial resistance by combination of two antibiotics: fusidic acid and rifampicin
31. Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus
32. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak
33. Methicillin-resistant staphylococci
34. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies
35. Current problems with methicillin-resistant Staphylococcus aureus
36. Bacteriological characters of strains of Staphylococcus aureus submitted to a reference laboratory related to methicillin resistance
37. Outbreak of accidental hexachlorophene poisoning in France
38. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins
39. Vancomycin
40. Treatment of infections by staphylococci and other Gram-positive bacteria with teicoplanin: an open study
41. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals
42. Antibacterial activity of teichomycin, a new glycopeptide antibiotic, in comparison to vancomycin
43. Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections
44. Mupirocin-resistant Staphylococcus aureus
45. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus
46. Another strain of methicillin-resistant Staphylococcus aureus epidemic in London
47. Ciprofloxacin treatment of Staphylococcus aureus infections
48. Effect of rifampin on nasal carriage of Staphylococcus aureus
49. The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci
50. Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: value of an isolation unit
51. Operating theatre acquired infection with a gentamicin-resistant strain of Staphylococcus aureus: outbreaks in two hospitals attributable to one surgeon
52. Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus
53. Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations
54. A prospective study of adverse reactions associated with vancomycin therapy
55. Vancomycin therapy for methicillin-resistant Staphylococcus aureus
56. In-vitro activity of rifampin alone and in combination with nafcillin and vancomycin against pathogenic strains of Staphylococcus aureus
57. In-vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species
58. In-vitro activity and human pharmacokinetics of teicoplanin
59. Interaction between vancomycin and rifampin against Staphylococcus aureus
60. Effect of rifampin on nasal carriers of coagulase-positive staphylococci
61. Teicoplanin
62. Teicoplanin-resistant coagulase-negative staphylococcus
63. The treatment of severe staphylococcal infections with vancomycin
64. Antistaphylococcal activity of rifampin with other antibiotics